Our RESETTM clinical trials with CABA-201 (investigational CD19-CAR T cell therapy) in lupus, myositis, systemic sclerosis, myasthenia gravis, and pemphigus vulgaris are now recruiting.
Recent News View All News
Upcoming Events View IR Calendar
European Alliance of Associations for Rheumatology (EULAR) 2025 Congress
Barcelona, Spain
Email Alerts
Sign up for email alerts for Press Releases & SEC Filings